# CyberMDx Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cybermdx-technologies

- Industry: Software
- Headquarters: New York, US
- Website: www.cybermdx.com
- Total disclosed funding: $10M
- Latest round: Series A (Jul 17, 2018)
- Investors on record: 2

## About

CyberMDx Technologies Inc. develops specialized cybersecurity solutions for healthcare, safeguarding medical devices and patient data from cyber threats.Founded in 2016, CyberMDx Technologies Inc. is based in New York, US. The company focuses on providing cybersecurity solutions tailored specifically for the healthcare sector. The founder, Amir Magner, has a history in entrepreneurship, having previously founded other ventures. The company raised USD 20.00 mn in its latest funding round led by Sham - Société Hospitalière d’Assurances Mutuelles, alongside investors such as Pitango Venture Capital and Qure Ventures. CyberMDx has completed a total of 3 deals, with the most recent deal occurring on February 1, 2022, when it was acquired by ForeScout Technologies, Inc., a portfolio company of Advent International and Crosspoint Capital Partners, with financial terms not disclosed.CyberMDX specializes in cybersecurity solutions tailored for the healthcare sector, focusing primarily on protecting medical devices and sensitive patient data from cyber threats. Their core offerings include advanced threat detection, real-time monitoring, and vulnerability management systems that integrate seamlessly with existing healthcare infrastructures. The primary end use cases address critical issues such as safeguarding patient privacy, ensuring compliance with regulatory standards, and maintaining the integrity of healthcare operations. CyberMDX serves a diverse client base, including hospitals, healthcare providers, and medical device manufacturers, particularly in North America and Europe, where the demand for robust cybersecurity measures is growing. The company’s products are designed to enhance the security posture of healthcare organizations, ultimately leading to improved patient outcomes and trust.The revenue model of CyberMDX is structured around subscription-based services that facilitate ongoing access to their cybersecurity solutions. Clients typically engage in annual agreements that encompass a suite of services, including system installation, continuous monitoring, and regular updates, tailored to meet the specific needs of healthcare environments. The transactions generally occur directly between CyberMDX and its B2B clients, which may include healthcare facilities and device manufacturers, ensuring that all parties adhere to industry standards for data security. Flagship products, such as their proprietary security management platform, are critical components of these agreements, designed to offer comprehensive protection against emerging cyber threats. Pricing plans are structured to accommodate various scales of operations, enabling healthcare organizations of all sizes to implement effective cybersecurity measures.In the future, CyberMDX intends to expand its product services, particularly in connected device types, following its acquisition by ForeScout Technologies, Inc. The recent funding will support these initiatives, enhancing their offerings to better address the evolving cybersecurity needs within healthcare environments. While specific upcoming products have not been detailed, the strategic focus on expanding into new markets, especially across North America and Europe, is anticipated, with efforts underway to enhance existing service capabilities by leveraging the combined resources of CyberMDx and ForeScout.

## Funding rounds

- Series A, Jul 17, 2018, $10M — Pitango, OurCrowd

## Investors

- Pitango (https://capitalatlas.ai/funds/pitango) — Series A
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series A